Breaking: EPO revokes Broad’s CRISPR patent

16-01-2020

Rory O'Neill

Breaking: EPO revokes Broad’s CRISPR patent

servickuz / shutterstock.com

In a dramatic reversal, a European Patent Office’s (EPO) board of appeal has upheld the revocation of a Broad Institute CRISPR/Cas9 patent.


European Patent Office, EPO, CRISPR, Kirkland & Ellis, Daniel Lim, enlarged board of appeal

LSIPR